Leo Pharmaceutical Products, Ltd.

Leo Pharmaceutical Products Ltd. A/s

Leo-pharma A/s

Erik T Hansen

Schneur Rachlin

Ole Bent Nielsen

Ian Ahnfelt-Ronne

Dorte Kirstein

Carsten Lund

Lene Hoffmeyer Ringborg

Niels Smidt Rastrup Andersen

The present invention relates to calcipotriol hydrate&#x2014;a new crystalline form of calcipotriol&#x2014;with superior technical properties and with superior stability.

Crystalline form of a vitamin D analogue

A container ( ) for a hypodermic syringe ( ) and of the type which allows it to be seen or observed in another manner that the container has been opened. The container ( ) comprises a plug ( ) having more than one tamper-proof mechanism. This ensures both that the hypodermic syringe ( ) can reach the user in a state which allows it to be seen whether it has been opened, and that, after use, it can be disposed of in such a state that re-use is impeded considerably.

Container for a hypodermic syringe

Substituted quinolines and leucotriene antagonism treatment therewith

Substituted quinolines and medicinal use thereof

Improved method for preparing penicillanic acid derivatives

Growing community of inventors

Fredensborg, Denmark

Erik T Hansen